Tag: ChAdOx1 nCoV-19

29
Jun

COVID-19 Vaccine

Vaccine against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)  Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the COronVIirus Disease 2019 (COVID-19) pandemic.    The UK drug manufacturer AstraZeneca has partnered with the University of Oxford to develop the adenovirus-vectored vaccine against SARS-CoV-2. An investigational adenovirus-vectored vaccine (ChAdOx1 nCoV-19: AZD1222) against SARS-CoV-2 is currently being tested in phases 2/3 clinical trials.

Read more